USP

Ampicillinnatrium

Name: Ampicillinnatrium
Brand: USP
Price: 340 EUR

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

Ampicillin Natriumsalz, D-(−)-α-Aminobenzylpenicillin Natriumsalz

Slide 1 of 1

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

125 MG

€ 340,00

Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen

Über diesen Artikel

Empirische Formel (Hill-System):

C₁₆H₁₈N₃NaO₄S

CAS-Nummer:

69-52-3

Molekulargewicht:

371.39

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329749023

MDL number:

MFCD00064313

Beilstein/REAXYS Number:

4119211

Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

Technischer Dienst

Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.

Unterstützung erhalten

SMILES string

[Na+].CC1(C)SC2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C([O-])=O

grade

pharmaceutical primary standard

API family

ampicillin

manufacturer/tradename

USP

mp

215 °C (dec.) (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

InChI

1S/C16H19N3O4S.Na/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8;/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23);/q;+1/p-1/t9-,10-,11+,14-;/m1./s1

InChI key

KLOHDWPABZXLGI-YWUHCJSESA-M

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel	PHR1424	A0166	1033407
USP 1033203 Ampicillin sodium	Supelco PHR1424 Ampicillin Sodium	Sigma-Aldrich A0166 Ampicillin sodium salt	USP 1033407 Ampicillin trihydrate
manufacturer/tradename USP	manufacturer/tradename -	manufacturer/tradename -	manufacturer/tradename USP
grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade -	grade pharmaceutical primary standard
format neat	format neat	format -	format neat
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) -	application(s) pharmaceutical (small molecule)
API family ampicillin	API family ampicillin	API family -	API family ampicillin
mp 215 °C (dec.) (lit.)	mp 215 °C (dec.) (lit.)	mp 215 °C (dec.) (lit.)	mp 198-200 °C (dec.) (lit.)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Biochem/physiol Actions

Wirkungsweise: Dieses Produkt ist ein β-Lactam-Antibiotikum, das die Zellwandsynthese von Bakterien hemmt, indem es Transpeptidasen auf der Innenoberfläche der Zellmembran der Bakterien deaktiviert.

Wirkungsweise der Resistenz: Die Verabreichung zusammen mit β-Lactamase spaltet den β-Lactam-Ring von Ampicillin und deaktiviert ihn.

Antimikrobielles Spektrum: Enthält sowohl grampositive (Benzylpenicillin-ähnliche) wie auch gramnegative (Tetracyclin- und Chloramphenicol-ähnliche) Bakterien.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

1033000

Ampicillin, United States Pharmacopeia (USP) Reference Standard

A1100000

Ampicillin trihydrate, European Pharmacopoeia (EP) Reference Standard

A1000000

Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard

PHR1393

Ampicillin Trihydrate, Pharmaceutical Secondary Standard; Certified Reference Material

1033407

Ampicillin trihydrate, United States Pharmacopeia (USP) Reference Standard

1033247

Ampicillin System Suitability Mixture, United States Pharmacopeia (USP) Reference Standard

BP785

Anhydrous ampicillin, British Pharmacopoeia (BP) Reference Standard

BP021

Ampicillin trihydrate, British Pharmacopoeia (BP) Reference Standard

PHR9060

D-(−)-α-Phenylglycine, certified reference material, TraceCERT^®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR9105

(2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-phenylacetic acid, certified reference material, TraceCERT^®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR2838

Ampicillin, pharmaceutical secondary standard, certified reference material

pictograms

GHS08

signalword

Danger

hcodes

H317,H334

pcodes

P261 - P280 - P284 - P304 + P340 - P342 + P311

Hazard Classifications

Resp. Sens. 1 - Skin Sens. 1

Lagerklasse

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs.

Mohamed F Mohamed et al.

PloS one, 9(12), e116259-e116259 (2015-01-01)

Staphylococcus pseudintermedius is a major cause of skin and soft tissue infections in companion animals and has zoonotic potential. Additionally, methicillin-resistant S. pseudintermedius (MRSP) has emerged with resistance to virtually all classes of antimicrobials. Thus, novel treatment options with new

Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.

Mohamed F Mohamed et al.

Antimicrobial agents and chemotherapy, 58(7), 4113-4122 (2014-05-07)

The seriousness of microbial resistance combined with the lack of new antimicrobials has increased interest in the development of antimicrobial peptides (AMPs) as novel therapeutics. In this study, we evaluated the antimicrobial activities of two short synthetic peptides, namely, RRIKA

Anti-tumor effects of flavonoids from the ethnic medicine Docynia delavayi (Franch.) Schneid. and its possible mechanism.

Xukun Deng et al.

Journal of medicinal food, 17(7), 787-794 (2014-06-19)

This study investigated the active components and the anti-tumor efficacy and mechanisms of the flavonoids from Docynia delavayi (Franch.) Schneid. (DDS). MTT assay was used to examine the growth inhibitory effects of the four flavonoids, including chrysin, quercetin, naringenin, and

Ligation-based assembly for constructing mouse synthetic scFv libraries by chain shuffling with in vivo-amplified VH and VL fragments.

Michiru Nishi et al.

Journal of immunological methods, 412, 53-69 (2014-07-11)

In vitro assembly of two or three PCR fragments using primers is a common method of constructing scFv fragments for display on the surface of phage. However, mismatch annealing often occurs during in this step, leading to cloning and display

Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Marta Putrinš et al.

Infection and immunity, 83(3), 1056-1067 (2015-01-07)

Uropathogenic strains of Escherichia coli (UPEC) are the major cause of bacteremic urinary tract infections. Survival in the bloodstream is associated with different mechanisms that help to resist serum complement-mediated killing. While the phenotypic heterogeneity of bacteria has been shown

Alle zugehörigen Dokumente anzeigen

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung